Estimating the effects of second-line therapy for type 2 diabetes mellitus: retrospective cohort study

OBJECTIVE: Metformin is the recommended initial drug treatment in type 2 diabetes mellitus, but there is no clearly preferred choice for an additional drug when indicated. We compare the counterfactual drug effectiveness in lowering glycated hemoglobin (HbA1c) levels and effect on body mass index (B...

Descripción completa

Detalles Bibliográficos
Autores principales: Gottlieb, Assaf, Yanover, Chen, Cahan, Amos, Goldschmidt, Yaara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Epidemiology/Health Services Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5730938/
https://www.ncbi.nlm.nih.gov/pubmed/29299328
http://dx.doi.org/10.1136/bmjdrc-2017-000435

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5730938/
https://www.ncbi.nlm.nih.gov/pubmed/29299328
http://dx.doi.org/10.1136/bmjdrc-2017-000435

Ejemplares similares